List of accepted abstracts for the 22nd International Symposium

Please Note: To be eligible to participate in the poster presentation competition make sure your CRSIC membership is not expiring before March 02, 2024.

The first 100 posters in the list will be presented on Day-1 (29-Feb-2024)

Sr. No. 101-194 posters will be presented on Day-2 (01-Mar-2024)

Sr. Abstract title

To be presented on Day-1 29-Feb-2024
1 3D printed microneedle patches for minimally invasive simultaneous transdermal delivery and detection of melatonin from interstitial fluid
3D spheroid model for lung adenocarcinoma: Understanding expression of epithelial-mesenchymal transition and metastatic markers during validation with anti-cancer drug
3 A smart pH responsive PTL loaded mesoporous silica nanoparticles for breast cancer therapy
4 Advancing Wound Care in diabetes through novel Doxycycline Hydrochloride (DOX HCl) loaded Filmogenic Solutions
5 An emerging platform for ferulic acid loaded nanostructured lipid carrier based drug delivery system for solubility enhancement and its antihypertensive activity
6 An in vitro –in vivo investigation of kaempferol loaded ethosomal gel in wound healing
7 An influence of formulation parameters on physical characteristics of self-assembling liposomes (leciplex®)
8 Apixaban solid dispersion approach for solubility and bioavailability enhancement
9 Aptamer tethered hetero-polymer conjugated mesoporous silica nanoparticles (MSNPs) mediated delivery of dual siRNA to induce apoptosis in breast cancer cells
10 Aptamer-tethered hyperbranched bis-MPA polyester dendrimers for targeted delivery of siRNA and gene silencing in breast cancer cells
11 Artificial in-vitro Blood-Brain Barrier Model for Preclinical Screen
12 Assessment of co-delivery of phytoconstituent and immunosuppressant in nanoemulsion based hydrogel for therapeutic management of psoriasis
13 Bioenhancer synergistically increases the permeation of Lopinavir via phospholipid complexation
14 Bioinspired long-acting mucoadhesive gastric patch for Levothyroxine delivery
15 Cationic nanocarriers for carrying macromolecular cargo
16 Chitosan-gum tragacanth gated mesoporous silica nanoparticles encapsulating Berbamine for targeted release in colon cancer
17 Clotrimazole loaded mesoporous silica nanoparticles based gel for the management of cutaneous candidiasis: A comprehensive study on design, development and optimization for topical delivery
18 Co-crystal with different co-former to enhance the solubility and bioavailability
19 Co-delivery of carbamide-luliconazole niosomes for the management of superficial Tinea infections
20 Computational approach toward the identification of novel genetic targets for hepatic cancer
21 Cyclodextrin-nanosponge-based in situ hydrogel for the co-delivery of the effective combinatorial drug regimen towards breast cancer therapy
22 Cytotoxic efficacies of Manilkara zapota extract against MCF-7 cell line
23 Decorated combinatorial nanostructured lipid carriers for the treatment of triple-negative breast cancer
24 Deep eutectic solvent: a promising vehicle for the design of ivermectin microemulgel formulation
25 Design and characterization of SLN loaded transdermal patch for treatment of psoriasis
26 Design and development of cyclodextrin nanosponges-based in situ gelling systems to co-deliver polyphenols for vaginal candidiasis therapy
27 Design and development of Cytarabine-loaded trehalose coated iron oxide nanoparticles: Evaluating its in vitro to in vivo anticancer activity
28 Design and development of lipid based self-emulsifying formulation of Andrographis paniculata by fluidized bed melt granulation technique
29 Design and development of mucoadhesive paliperidone nanoformulations for nasal delivery
30 Design and Evaluation of Osmotic controlled release oral drug delivery system of Carbamazepine by QbD approach
31 Design, development and characterization of Clopidogrel bisulphate incorporated nasal in-situ gelling system for ischemic stroke
32 Design, development and characterization of Boswellia serrata loaded ethosomal gel for anti-inflammatory potential
33 Design, development and characterization of multiparticulate floating drug delivery system of Nintedanib
34 Design, development, and evaluation of cilnidipine ODT using co-processed excipient
35 Development and characterization of herbal nanoparticles of Genistein for the treatment of hepatocellular carcinoma
36 Development and characterization of inhaled formulation for the treatment of Pulmonary fibrosis
37 Development and characterization of nanocarrier loaded microneedles for the Psoriatic arthritis
38 Development and characterization of novel lipidic nanocarriers: A breakthrough approach to Enhance drug permeation and bioavailability
39 Development and evaluation of biocompatible PLGA-gelatin copolymer for 3D printing application
40 Development and evaluation of Lacidipine -phospholipid complex
41 Development and evaluation of Lysozyme loaded Aquasome as a novel carrier for delivery of protein molecule through dry powder inhaler
42 Development and evaluation of multiparticulate dosage form of teneligliptin (IR) and metformin (ER) for sprinkle application
43 Development and evaluation of nasal delivery system of carbamazepine
44 Development and evaluation of novel ionic liquid- polymer based hybrid nanoformulation of curcumin
45 Development and evaluation of Olanzapine sublingual film by QbD approach
46 Development and evaluation of Oral film for attention deficit hyperactivity disorder.
47 Development and evaluation of Verapamil HCl extended-release pellets using fluidized bed processor
48 Development and optimization of Nanogel containing ion chelator for the treatment of chronic wound
49 Development and optimization of Proliposome based Dry Powder Inhalation for Chronic Obstructive Pulmonary Disease
50 Development and optimization of multi-particulate system for nasal delivery of Cilnidipine
51 Development and QbD based optimization of VEGFR inhibitor loaded lipid emulsion system for lung cancer treatment
52 Development of a MARS-based vector system for monoclonal antibody production in CHO cells
53 Development of Cocrystals of Nintedanib for the enhancement of bioavailability
54 Development of Cubosome-loaded topical spray dressing of kojic acid dipalmitate for wound healing
55 Development of herbal formulation for inflammation management
56 Development of Nanostructured Lipid Carriers of Allantoin for wound healing.
57 Development of oral thin film for fixed dose composition
58 Development of silver nanoparticle incorporated core-shell nanofibers for diabetic foot ulcer management
59 Development of stable anti-leukemic drug-loaded novel lipid-based drug product
60 Development of targeted inhalation formulations with combination of anti-TB drugs
61 Development of triple-layered nanofibrous bandage as a wound dressing material
62 Development, characterization and in-vivo potential of thrombus targeted Abciximab coated mesoporous silica nanoparticles in thrombotic event
63 Development, characterization, and in-vitro evaluation of inhalable hyaluronic acid-decorated Chitosan–PLGA nanoparticles for targeted Erlotinib hydrochloride delivery in non-small cell lung cancer
64 Development, evaluation, and optimization of Microsponge-loaded Clotrimazole Lipstick for controlled release: An innovative approach to combat Lip Fungal Infections
65 DOE assisted formulation and evaluation of ethosome loaded nanogel of Karanjin for psoriasis
66 DOE assisted formulation development and evaluation of niosomes loaded in-situ gel for nose to brain drug delivery
67 Domperidone electrospun nanofiber mats: A novel approach for ultrafast drug delivery technologies
68 Dual ligand surface modified Stevioside loaded nanostructured lipid carriers for effective targeting of breast cancer
69 Effect of oxygen generators on Indocyanine green and IR 820 mediated phototherapy against oral cancer
70 Engineering of modified chitosan encased polymersomes in effective management of glioblastoma multiforme through lactoferrin integration
71 Enhancement in brain targeting of hydrophilic drug through protein functionalized lipid-drug conjugated nanoparticles: In-silico screening, formulation development and in-vivo studies
72 Enhancement of solubility of celecoxib using different solubility enhancement technique
73 Enhancing oral bioavailability: Synthesis, characterization and in-vitro evaluation of a trypsin- resistant Salmon calcitonin analog
74 Exploration of curcumin-ascorbic acid cocrystal-based formulations for enhanced physico-technological attributes
75 Exploring potential of combinatorial therapy of curcumin and cyclosporin in biocompatible lipomeric hydrogel for Rheumatoid Arthritis
76 Exploring the therapeutic potential of HUGLP-1 loaded formulation in Type-2 Diabetes Mellitus: From preparation to in vivo assessment
77 Fabrication and characterization of depot parenteral formulation for treatment of mental disorder
78 Fabrication and characterization of topical dorzolamide loaded nanoparticles using Box-Behnken design
79 Fabrication and evaluation of long-acting Primaquine prodrug loaded polymeric nanorods prepared by mechanical stretching
80 Fabrication of solid dispersion incorporated Indomethacin Oro-dispersible tablet to improve its dissolution
81 Fabrication, optimization, and characterization of drug-loaded nanostructured lipid carriers for the treatment of chronic wounds
82 Fast dissolving oral films of Dapoxetine hydrochloride using solvent-casting method for improved patient compliance
83 Film formulation for value addition in wound dressing for effective exudate management
84 Formulating a self-emulsifying drug delivery system of Oroxylum indicum extract for immuno-stimulant activity
85 Formulating freezing mix for cryopreservation of A549 spheroids
86 Formulation and evaluation of Carvedilol loaded Proliposome to improve bioavailability
87 Formulation and characterization of nanovesicular system containing antifungal drug.
88 Formulation and characterization of Empagliflozin: Metformin cocrystals that enhance the biopharmaceutical properties of the drug
89 Formulation and characterization of long-acting biodegradable anti-VEGF loaded implant for the treatment of AMD
90 Formulation and characterization of mirtazapine loaded cubosomal in-situ gel for intranasal delivery.
91 Formulation and characterization of topical herbal nanoemulgel for the management of Rheumatoid Arthritis
92 Formulation and development of long-circulating liposomes of Voriconazole for the treatment of systemic fungal infections
93 Formulation and development of solidified deep eutectic solvent for enhancement of solubility and oral bioavailability of poorly water-soluble drug Zileuton
94 Formulation and evaluation of a nanosuspension based thermoreversible in situ nasal gel of an antipsychotic drug using statistical design
95 Formulation and evaluation of Besifloxacin HCl Solid dispersion incorporated Ophthalmic film
96 Formulation and evaluation of Brinzolamide β-cyclodextrin nanosponges for treatment of glaucoma
97 Formulation and evaluation of Clozapine buccal patch as novel drug delivery for antipsychotic effect
98 Formulation and evaluation of core shell nanoparticle laden in situ gel for corneal neovascularization
99 Formulation and evaluation of Esomeprazole magnesium trihydrate loaded microspheres for treatment of ulcers.
100 Formulation and evaluation of herbal skin care preparation containing extracts of Turmeric Rhizome and Berberis Root at which shea butter as an excipient

To be presented on Day-2 01-March-2024
101 Formulation and evaluation of in situ gel for nose to brain drug delivery
102 Formulation and evaluation of liquisolid tablets of poorly soluble Voriconazol
103 Formulation and evaluation of mucoadhesive nanocarrier gel for vaginal candidiasis
104 Formulation and evaluation of mucoadhesive probiotic tablet for recolonization of vaginal microbiota
105 Formulation and evaluation of ocular mucoadhesive nanocarrier gel for bacterial keratitis
106 Formulation and evaluation of orodispersible film of Piroxicam (BCS class II drug)
107 Formulation and evaluation of pediatric dosage form using Loratadine ionic liquid salt
108 Formulation and evaluation of Proniosomal oral delivery of Irbesartan
109 Formulation and evaluation of Quercetin ethosomal hydrogel for topical delivery system
110 Formulation and evaluation of Selegiline loaded microneedle array patch for depression disorder
111 Formulation and evaluation of skin care preparation containing extract of Curcuma longa and Berberis aristasta
112 Formulation and evaluation of solid dispersion-based tablet of Voriconazole
113 Formulation and evaluation of solid self microemulsifying drug delivery system of celecoxib.
114 Formulation and evaluation of topical drug delivery system for management of rheumatoid arthritis
115 Formulation and in-vitro evaluation of the therapeutic potential of Bacillus coagulans BCM9 containing probiotic herbal toothpaste
116 Formulation and optimization of drug loaded solid lipid nanoparticles for the treatment of Tuberculosis
117 Formulation development and evaluation of Indian royal jelly – jam and chewable tablets as nutraceutical products
118 Formulation development and evaluation of nanocrystals loaded in mucoadhesive microspheres for solubility enhancement of Zingerone
119 Formulation development of Drotaverine HCl loaded sustained release microspheres of chitosan and its thiolated derivatives
120 Formulation of a sustained release transdermal system for Spasticity
121 Formulation of polyherbal emulgel by quality by design (QbD) approach for Alopecia
122 Formulation, optimization and characterization of HA-SeNPs loaded hydrogel for Psoriasis management using QbD-based approach
123 Formulation, optimization and evaluation of bile salt based nano vesicular carriers for topical delivery of Posaconazole
124 Formulation, development & characterization of floating microspheres of Tizanidine hydrochloride.
125 Harnessing the potential of calcium channel blocker against Alzheimer’s disease using intranasal thermosensitive in situ gelling system
126 Hollow microneedle patches: A transdermal innovation for Insulin delivery
127 Hot melt extrusion of poorly soluble Ritonavir using Poloxamer
128 Inclusion complexation: An effective approach to enhance stability of Tenofovir Disoproxil Fumarate
129 Industrially feasible formulation strategies for enhancing oral bioavailability of BCS class II drugs
130 Inhalable Clofazimine nanoclusters for treatment of Tuberculosis in mice
131 Innovating hair wellness: Crafting an advanced polyherbal shampoo with integrated development, evaluation, optimization, and comparative studies
132 Integrating nanofiber structural precision and injectable hydrogels for enhanced healing in volumetric muscle loss: A unified therapeutic strategy
133 Intranasal transfersomes based in situ gel for enhanced brain distribution
134 Investigating the effect of drug loading process parameters for mesoporous silica nanoparticles using Taguchi design of experiment method
135 Investigation into development of Gamma-Oryzanol solid-SMEDDS for hypercholesterolemia
136 Investigation of impact of lipids on the development of Doxorubicin HCl loaded UFA-NP
137 Investigation on the potential of liquisolid compact incorporated in mucoadhesive vaginal tablets for solubility enhancement of Metronidazole
138 Investigations on role of penetration enhancers to improve permeability of a model drug for transdermal delivery
139 Khellin loaded MCM-48 mesoporous silica nanocarriers for the treatment of Vitiligo
140 Liposomal Cefoperazone inhalable formulation for biofilm eradication
141 Localized delivery of repurposed Ketoconazole using nanostructured lipid carriers-based gel: A potential strategy for skin cancer treatment.
142 Luliconazole nanocrystal embedded nanogel: Formulation, characterization and in-vitro evaluation
143 Mangiferin based niosomal in situ gel: Formulation and characterization
144 Mesoporous silica as a carrier for amorphous solid dispersion of Itraconazole
145 Microparticles for colonic controlled drug delivery
146 Mitochondria-targeted docetaxel loaded dqasomes for the treatment of multi-drug resistant breast tumor: In vitro and in vivo studies.
147 Modulating solid state characteristics of SGLT-2 inhibitors via cocrystals approach
148 Myricetin loaded cross linked oral chitosan nanoparticles for the management of Type 2 Diabetes
149 Nanogold Berberine: Enhanced efficacy in a tumor microenvironment simulating 3D spheroid model
150 Nanoliposomes embedded nanocochleates for improving Artemether lumefantrine oral bioavailability
151 Nasal Donepezil Cubosomes: A novel realm in Alzheimer’s therapy
152 Nose-to-brain delivery of Atazanavir sulfate and Resveratrol loaded NLC for the treatment of HIV  latency in CNS
153 Novel nanofiber insert for management of Dry Eye disease
154 Numerical modelling of nutrient medium transport and drug diffusion in human microphysiological skin system for preclinical evaluation of drugs
155 Oa-g4 dnps and nac-g4 dnps nanoparticulate system(s) for nose to brain delivery: Potentiated inhibition of choline esterase and amyloid fibril formation to treat Alzheimer’s disease
156 Optimization and characterization of lipid-based nanocarriers for the treatment of Amyotrophic lateral sclerosis
157 Oral bioavailability enhancement of Niclosamide to explore its repurposing potential
158 Paclitaxel and Imatinib Tosylate coloaded PLGA nanoparticles coated with protamine having promising efficacy on breast cancer cell line
159 Pharmacodynamic and pharmacokinetic studies of developed transdermal drug delivery system of Mirtazapine
160 Pharmacokinetic assessment and mucosal toxicity study of vaginal multipurpose prevention technology
161 Polycystic ovary syndrome treatments: Bilayer tablet
162 Polymer based antimicrobial herbal essential oil coatings as potential urethral biomaterial: Preparation and in vitro evaluation
163 Polyvinylpyrrolidone and carnauba wax based extended-release oral formulations of a liquid drug Valproic acid
164 Precision drug discovery from Zingiber officinalis: Unraveling therapeutic insights for Rheumatoid Arthritis through innovative in-silico approaches and controlled release strategies
165 Preparation and characterisation of microneedle scleral patch for minimally invasive delivery of regorafenib to treat choroidal neovascularization
166 Preparation and characterization of canagliflozin-loaded nanostructured lipid carriers (NLC) for improved oral bioavailability
167 Preparation and evaluation of niosomal Luliconazole gel for topical drug delivery
168 Pulmonary delivery of spray-dried gelatin microspheres with improved solubility and controlled release of Lovastatin
169 QbD enabled Solid Dispersion of single ethoxylated solubilizer, soluplus for enhanced solubility and permeability of BCS IV drugs
170 Repurposed-Mebendazole loaded nano-structured lipid carriers-based gel: A promising approach in skin cancer treatment
171 Revolutionizing biofilm treatment: Bacteriophage microparticles in topical gel
172 Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability
173 Sesamol – hydroxypropyl β-cyclodextrin loaded polymeric hydrogel for wound healing
174 Sinuflora: A nasal synbiotic formulation for prophylactic and therapeutic management of nasal infections
175 Soluplus based Apixaban solid dispersion: Optimization, ex-vivo permeability, and in-vivo pharmacokinetic studies
176 Spray dried mucoadhesive microspheres of Tapentadol Hydrochloride: Development, characterization and evaluation
177 Stability enhancement using cyclodextrin complexation: an in vitro-in silico correlation
178 Stimuli responsive polymeric carriers for targeted drug delivery of anti-acne agent
179 Studies on cocrystallization of poorly water soluble drug for solubility enhancement
180 Studies on ionic liquids of Acyclovir as penetration enhancer in transdermal drug delivery system.
181 Studies on mucoadhesive intranasal nanoemulsions of Iloperidone for brain delivery
182 Studies on polyelectrolyte complex based nanoparticles of water soluble drug for Uveitis
183 Studies on thermoresponsive and mucoadhesive gels of Anti-Parkinson’s drug for nasal delivery
184 Surface spiked lipidic nanocarriers for the brain targeted drug delivery through intranasal route
185 Sustained delivery of Interleukin-1 receptor antagonist (IL-1Ra) using polymeric nanocomplexes for the treatment of Type 1 Diabetes Mellitus
186 Synthesis and characterization of Bimetallic Au-Ag nanoparticles loaded nanofibers for the potential treatment against antimicrobial resistance bacteria
187 Tamoxifen-loaded solid lipid nanoparticles conjugated with N-acetyl-D-glucosamine for improved targeted delivery in breast cancer
188 Targeted delivery of Palbociclib Loaded Chitosan-g-estrone Nanoparticles for hypoxic Breast Tumour: Development, in vivo optical and ultrasound/photoacoustic Imaging
189 Targeted Pulmonary Tuberculosis therapy: development and evaluation of spray-dried microspheres loaded dry powder for inhalation
190 Ternary solid dispersion system of Etoricoxib for improving its solubility
191 Formulation and development of Irinotecan loaded spherulites
192 Unveiling the anti-cancer potency of ferroptosis and apoptosis inducing agents through a targeted co-delivery system
193 Vaginal suppository of Lawsone inclusion complex for treatment and prophylaxis of vaginal candidiasis
194 Αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of Docetaxel against breast cancer